Teleconference: Lysosomal Storage Diseases - Preview to WORLD Symposium 2013 (14:00 GMT / 9:00 AM EST)

Time & Location

Originally Presented: February 4, 2013 2:00 PM, Teleconference


GLG Expert Contributor


    Note: Time above is GMT; for US clients, this Teleconference will occur at 9:00 AM EST Talking Points: • Overview of Lysosomal Storage Diseases and unmet need • Current treatments for Gaucher’s (Ceredase/Cerezyme, VPRIV, Zavesca, Elelyso) and Fabry’s (Fabryzyme, Replagal) • Current treatments for Pompe (Myozyme/Lumizyme), MPS I (Aldurazyme), MPS II (Elaprase) and MPS VI (Naglazyme) • Review of published data on pipeline drugs such as Eliglustat, Migalastat, Duvoglustat, BMN 701 and GALNS Please note Dr. Whitley cannot discuss the particulars of ongoing clinical trials in which he is involved, and may decline to answer questions on certain topics related to confidential matters.

View Webcasts & Teleconferences in Healthcare

View All Webcasts & Teleconferences in Healthcare

About GLG Live Meetings

A program focused on educating business and investment professionals through seminars on current trends and core concepts in various industries. Detailed workbooks distributed at the Seminars provide educational reference materials for later review. GLG Live Meetings enable clients to increase thier own industry education by proposing new seminar topics or adding agenda terms to currently scheduled seminars.